Fresenius SE

All - 2006

22.12.2006Fresenius Medical Care donates € 150,000 to aid dialysis patients
PDF Text as PDF-file
19.12.2006Fresenius ProServe focuses on hospital business – agreement reached on the sale of Pharmaplan GmbH
PDF Text as PDF-file
18.12.2006Phase II/III pivotal study with trifunctional antibody removab® shows encouraging results in malignant ascites
PDF Text as PDF-file
04.12.2006Shareholders approve conversion of Fresenius AG into a European Company (SE) and share split at Extraordinary General Meeting
PDF Text as PDF-file
29.11.2006Fresenius Medical Care Turns Ten Years Donating Funds to the National German Kidney Patient Association
PDF Text as PDF-file
21.11.2006European Commission grants Orphan Drug Designation for the removab® antibody to treat gastric cancer
21.11.2006Fresenius Medical Care Announces Positive Results from PhosLo CARE-2 Study
PDF Text as PDF-file
PDF Text as PDF-file
15.11.2006Fresenius Medical Care Completes the Acquisition of the Phosphate Binder Business From Nabi Biopharmaceuticals
15.11.2006Fresenius Awards 2006 Inventors’ Prize
PDF Text as PDF-file
PDF Text as PDF-file
09.11.2006Fresenius Inventors’ Fair: 20 select innovators and researchers showcase their ideas during MEDICA
PDF Text as PDF-file
31.10.2006Fresenius Medical Care Reports Excellent Revenue and EBIT Growth in the Third Quarter and Nine Months 2006;
Outlook for 2006 Upgraded
(for additional tables see PDF-file)
31.10.2006Fresenius AG, first nine months 2006:
Excellent sales and earnings growth in all business segments - Strong third quarter - Outlook raised
PDF Text as PDF-file
PDF Text as PDF-file
19.10.2006Fresenius Medical Care Announces New Sourcing and Supply Agreement with Amgen
PDF Text as PDF-file
12.10.2006Fresenius Medical Care to acquire phosphate binder business from Nabi Pharmaceuticals
PDF Text as PDF-file
11.10.2006Fresenius plans conversion of Fresenius AG into European Company (SE) and share split
PDF Text as PDF-file
19.09.2006Taking innovations from the drawing board to the hospital ward: the Fresenius Inventors’ Fair 2006
PDF Text as PDF-file
11.09.2006HELIOS obtains antitrust approval to acquire HUMAINE Kliniken
PDF Text as PDF-file
09.08.2006Fresenius Inventors’ Fair 2006: Fresenius Group supports researchers and inventors
PDF Text as PDF-file
03.08.2006First half of 2006: Firmly on growth track; excellent operating performance in all segments; full-year sales and earnings forecast raised (for additional tables see PDF-File)
PDF Text as PDF-file
03.08.2006Fresenius Medical Care Reports Second Quarter and Six Months 2006 Results; Outlook for 2006 Upgraded (for additional tables see pdf file)
PDF Text as PDF-file
20.07.2006Fresenius Medical Care Receives Regulatory Approval for New Phosphate Binding Agent in Germany
PDF Text as PDF-file
26.06.2006New 5008 Therapy System Wins Design Award
PDF Text as PDF-file
23.06.2006Fresenius Biotech Reports Encouraging Phase IIa Results for its Trifunctional Antibody Removab in Ovarian Cancer Patients: Higher Dose Regimen Improves Tumor Response Without Affecting Good Tolerability
PDF Text as PDF-file
02.06.2006Renal Care Group Subpoenaed Regarding Stock Option Program
PDF Text as PDF-file
11.05.2006Study Shows: Hemodiafiltration Reduces Mortality for Patients with Chronic Kidney Disease by 35 Percent
PDF Text as PDF-file
09.05.2006Fresenius Medical Care: Shareholders Approve Ninth Consecutive Annual Dividend Increase and Elect Supervisory Board
PDF Text as PDF-file
03.05.2006Fresenius Medical Care Reports First Quarter 2006 Results; Excellent Start into the Year 2006 (for additional tables see pdf file)
PDF Text as PDF-file
03.05.2006First quarter 2006: Extremely strong start into fiscal year 2006 (for additional tables see PDF-File)
PDF Text as PDF-file
27.04.2006Fresenius Medical Care Adopts Section 404 Sarbanes-Oxley Rules Early
PDF Text as PDF-file
10.04.2006Fresenius Medical Care Completes Divestiture of Facilities in Connection with Renal Care Group Acquisition
PDF Text as PDF-file
04.04.2006Fresenius Biotech and Nabi Biopharmaceuticals sign agreement for the clinical development and the marketing of ATG Fresenius S in the U.S.
PDF Text as PDF-file
31.03.2006Fresenius Medical Care Announces Closing of the Renal Care Group Acquisition
PDF Text as PDF-file
30.03.2006Fresenius Redeems Remaining Amount of € 300 million Series A Senior Notes
PDF Text as PDF-file
24.03.2006Fresenius Medical Care expands Production Capacity for Dialyzers in North America
PDF Text as PDF-file
20.03.2006Fresenius Continues Expansion in the German Hospital Market and Agrees to Acquire the HUMAINE Kliniken
PDF Text as PDF-file
22.02.2006Fiscal Year 2005: Excellent sales and earnings growth
13th consecutive dividend increase proposed
Outlook 2006: Sales of approx. € 10.5 billion and net income growth of more than 30 % expected (for additional tables see pdf-file)
PDF Text as PDF-file
22.02.2006Fresenius Medical Care reports Fourth Quarter and Full Year 2005 Results (for additional tables see pdf-file)
PDF Text as PDF-file
15.02.2006Fresenius Medical Care Announces Signing of Definitive Agreement to Divest Facilities in Connection with Renal Care Group Acquisition
PDF Text as PDF-file
13.02.2006Fresenius Medical Care Successfully Completes the Conversion of Preference Shares and the Transformation into KGaA
PDF Text as PDF-file
08.02.2006Final Results of Preference Share Conversion
First trading day of KGaA shares including new ordinary shares scheduled for February 13, 2006
PDF Text as PDF-file
03.02.2006Successful Conversion Period for Fresenius Medical Care Preference Shares; Approximately 95% of Preference Shares Tendered
PDF Text as PDF-file
22.01.2006Fresenius Medical Care wins German Business Innovation Award
PDF Text as PDF-file
13.01.2006Fresenius AG Closes Debt Tender Offer
13.01.2006Fresenius AG announces pricing of €1 billion bond issue and successful completion of tender offer
06.01.2006Enzon and Fresenius end agreement for development and marketing of ATG-Fresenius S in the U.S.
PDF Text as PDF-file
04.01.2006Fresenius Medical Care: Share Conversion Offer to Start on January 6, 2006 / Offer period of 4 weeks
04.01.2006Fresenius AG specifies plans for a bond issue in January
Home  >  Press  >  Press Releases  >  All  >  2006